BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 45 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,586 | -91.9% | 137,860 | -16.2% | 0.00% | – |
| Q2 2023 | $339,082 | -37.6% | 164,603 | -0.1% | 0.00% | – |
| Q1 2023 | $543,520 | +55.8% | 164,703 | -22.6% | 0.00% | – |
| Q4 2022 | $348,833 | -67.8% | 212,703 | -13.1% | 0.00% | -100.0% |
| Q3 2022 | $1,082,000 | +109.3% | 244,803 | +30.6% | 0.00% | 0.0% |
| Q2 2022 | $517,000 | -19.2% | 187,403 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $640,000 | -15.6% | 190,403 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $758,000 | +14.8% | 189,503 | -11.4% | 0.00% | 0.0% |
| Q3 2021 | $660,000 | -13.0% | 213,768 | +7.0% | 0.00% | 0.0% |
| Q2 2021 | $759,000 | +0.9% | 199,743 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $752,000 | -52.1% | 220,678 | -36.4% | 0.00% | -50.0% |
| Q4 2020 | $1,570,000 | -67.9% | 347,006 | +20.2% | 0.00% | -66.7% |
| Q3 2020 | $4,884,000 | +71.4% | 288,675 | +13.6% | 0.01% | +50.0% |
| Q2 2020 | $2,849,000 | +205.7% | 254,175 | +26.5% | 0.00% | +300.0% |
| Q1 2020 | $932,000 | +79.2% | 200,950 | +65.3% | 0.00% | 0.0% |
| Q4 2019 | $520,000 | +53.8% | 121,600 | +40.3% | 0.00% | – |
| Q3 2019 | $338,000 | – | 86,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |